In a melanoma study with the same regimen, tumour biopsy analysis suggested early recovery of MGMT activity, within 24 h, even when lomeguatrib doses were increased to 60 and 80 mg per day (Ranson et al, 2006). This evidence concerns the gene MGMT and neoplasm.